Infectious Diseases
What We Know Now: Vaccine Effectiveness in Preventing Hospitalization
Vanderbilt-led study evaluates how the SARS-CoV-2 vaccines are working in real-world settings.
Respiratory Microbiome May Impact COVID-19 Severity
New study will detail role of upper respiratory tract bacteria in susceptibility to SARS-CoV-2.
Facing Down COVID-19 at Every Level
From drug discovery to health equity, Vanderbilt joins worldwide leaders to conquer the pandemic.
Urinary E. coli : Harmless or Harmful?
Downloadable dataset catalogues clinical isolates by morphology and symptomatology.
Population-based Study Connects Diet and Gut Flora
Prospective, longitudinal data from a population-based study offer insights on flora diversity and species.
Resurrecting Subcutaneous Insulin Aspart for Diabetic Ketoacidosis
Physicians are implementing an old gold standard to free up ICU beds during the pandemic.
Forging a Shield for Thousands of Long-Term Care Patients
A COVID-19 strike force held infection and fatalities in Middle Tennessee LTCs to nationwide lows.
Upper Airway Lactobacillus to Reduce Risk of Wheezing Illness?
Bacteria could offer a biomarker and prevention strategy.
Organizing Health Systems to Address COVID-19 Health Inequities
Vanderbilt’s data-driven, systems approach aims for meaningful change.
